SC
DGX icon

Schubert & Co’s Quest Diagnostics DGX Stock Holding History

Schubert & Co’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-45
Closed -$6.37K – 440
2023
Q1 		$6.37K Sell
45
-11
-20% -$1.57K 0.01% 359
2022
Q4 		$8.76K Buy
56
+17
+44% +$2.44K 0.01% 251
2022
Q3 		$5K Sell
39
-6
-13% -$790 ﹤0.01% 384
2022
Q2 		$6K Buy
45
+30
+200% +$4.09K 0.01% 284
2022
Q1 		$2K Sell
15
-3
-17% -$418 ﹤0.01% 381
2021
Q4 		$3K Buy
+18
New +$2.74K ﹤0.01% 216

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Schubert & Co's DGX Position: Q2 2023 in Review

Schubert & Co sold out of Quest Diagnostics (DGX) in Q2 2023, closing a stake of 45 shares — an estimated $6.37K sold.

Schubert & Co first reported a position in DGX in Q4 2021 and held it in 6 quarters. The position peaked at $8.76K in Q4 2022. 818 funds tracked by Wall St. Rank hold DGX as of Q2 2023.

  • Schubert & Co reported no remaining Quest Diagnostics position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 45 Quest Diagnostics shares in Q2 2023, an estimated $6.37K.
  • Schubert & Co first reported a position in Quest Diagnostics in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Quest Diagnostics position peaked at $8.76K in Q4 2022.
  • 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.